Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from peptides may help the body build an immune response to kill
cytomegalovirus.
PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in
preventing cytomegalovirus in healthy participants.